Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 3
2006 11
2007 16
2008 13
2009 9
2010 13
2011 15
2012 20
2013 20
2014 17
2015 19
2016 24
2017 20
2018 21
2019 28
2020 24
Text availability
Article attribute
Article type
Publication date

Search Results

238 results
Results by year
Filters applied: . Clear all
Page 1
The Role of Resveratrol in Cancer Therapy.
Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. Ko JH, et al. Among authors: ahn ks. Int J Mol Sci. 2017 Dec 1;18(12):2589. doi: 10.3390/ijms18122589. Int J Mol Sci. 2017. PMID: 29194365 Free PMC article. Review.
Focus on Formononetin: Anticancer Potential and Molecular Targets.
Ong SKL, Shanmugam MK, Fan L, Fraser SE, Arfuso F, Ahn KS, Sethi G, Bishayee A. Ong SKL, et al. Among authors: ahn ks. Cancers (Basel). 2019 May 1;11(5):611. doi: 10.3390/cancers11050611. Cancers (Basel). 2019. PMID: 31052435 Free PMC article. Review.
Targeting transcription factor STAT3 for cancer prevention and therapy.
Chai EZ, Shanmugam MK, Arfuso F, Dharmarajan A, Wang C, Kumar AP, Samy RP, Lim LH, Wang L, Goh BC, Ahn KS, Hui KM, Sethi G. Chai EZ, et al. Among authors: ahn ks. Pharmacol Ther. 2016 Jun;162:86-97. doi: 10.1016/j.pharmthera.2015.10.004. Epub 2016 Feb 12. Pharmacol Ther. 2016. PMID: 26478441 Review.
Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
Shrimali D, Shanmugam MK, Kumar AP, Zhang J, Tan BK, Ahn KS, Sethi G. Shrimali D, et al. Among authors: ahn ks. Cancer Lett. 2013 Dec 1;341(2):139-49. doi: 10.1016/j.canlet.2013.08.023. Epub 2013 Aug 17. Cancer Lett. 2013. PMID: 23962559 Review.
Potential of Zerumbone as an Anti-Cancer Agent.
Girisa S, Shabnam B, Monisha J, Fan L, Halim CE, Arfuso F, Ahn KS, Sethi G, Kunnumakkara AB. Girisa S, et al. Among authors: ahn ks. Molecules. 2019 Feb 18;24(4):734. doi: 10.3390/molecules24040734. Molecules. 2019. PMID: 30781671 Free PMC article. Review.
NF-κB in cancer therapy.
Li F, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G. Li F, et al. Among authors: ahn ks. Arch Toxicol. 2015 May;89(5):711-31. doi: 10.1007/s00204-015-1470-4. Epub 2015 Feb 18. Arch Toxicol. 2015. PMID: 25690730 Review.
Pharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy.
Ko JH, Arfuso F, Sethi G, Ahn KS. Ko JH, et al. Among authors: ahn ks. Int J Mol Sci. 2018 Dec 14;19(12):4048. doi: 10.3390/ijms19124048. Int J Mol Sci. 2018. PMID: 30558157 Free PMC article. Review.
Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies.
Lam HY, Tergaonkar V, Ahn KS. Lam HY, et al. Among authors: ahn ks. Biosci Rep. 2020 Apr 30;40(4):BSR20200256. doi: 10.1042/BSR20200256. Biosci Rep. 2020. PMID: 32186703 Free PMC article.
Anti-cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models.
Halim CE, Xinjing SL, Fan L, Bailey Vitarbo J, Arfuso F, Tan CH, Narula AS, Kumar AP, Sethi G, Ahn KS. Halim CE, et al. Among authors: ahn ks. Pharmacol Res. 2019 Sep;147:104327. doi: 10.1016/j.phrs.2019.104327. Epub 2019 Jul 5. Pharmacol Res. 2019. PMID: 31283981 Review.
Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway.
Lee JH, Chinnathambi A, Alharbi SA, Shair OHM, Sethi G, Ahn KS. Lee JH, et al. Among authors: ahn ks. Pharmacol Res. 2019 Dec;150:104504. doi: 10.1016/j.phrs.2019.104504. Epub 2019 Oct 31. Pharmacol Res. 2019. PMID: 31678208
238 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page